<DOC>
	<DOCNO>NCT00379288</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety mometasone furoate/formoterol ( MF/F ) meter dose inhaler ( MDI ) 200/10 mcg twice-a-day ( BID ) MF/F MDI 400/10 mcg BID two dos fluticasone/salmeterol combination ( F/SC ) ( 250/50 mcg BID 500/50 mcg BID ) subject persistent asthma require maintenance treatment inhaled glucocorticosteroids ( ICS ) ; evaluator-blind . In addition , extrapulmonary effect 24-hour plasma cortisol area curve ( AUC ) , MF/F MDI 200/10 mcg BID , MF/F MDI 400/10 mcg BID , F/SC MDI 250/50 mcg BID , F/SC MDI 500/50 mcg BID evaluate .</brief_summary>
	<brief_title>Study Mometasone Furoate/Formoterol Combination Fluticasone/Salmeterol Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids ( P04139 )</brief_title>
	<detailed_description />
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Subjects either sex race , least 12 year age , diagnosis asthma least 12 month . Use medium high daily dose ICS ( alone combination longacting betaagonist [ LABA ] ) least 12 week prior Screening stable regimen least 2 week prior Screening . Medium daily dos ICS : &gt; 500 1000 mcg beclomethasone chlorofluorocarbon ( CFC ) &gt; 250 500 mcg beclomethasone hydrofluoroalkane ( HFA ) &gt; 600 1000 mcg budesonide dry powder inhaler ( DPI ) &gt; 1000 2000 mcg flunisolide &gt; 250 500 mcg fluticasone 400 mcg MF &gt; 1000 2000 mcg triamcinolone acetonide High daily dos ICS : &gt; 1000 mcg beclomethasone CFC &gt; 500 mcg beclomethasone HFA &gt; 1000 mcg budesonide DPI &gt; 2000 mcg flunisolide &gt; 500 mcg fluticasone &gt; 400 mcg MF &gt; 2000 mcg triamcinolone acetonide If inherent harm change subject 's current asthma therapy , subject must discontinue prescribed ICS ICS/LABA combination Baseline . Must show evidence reversibility within last 12 month Screening Period . Historical reversibility define increase absolute force expiratory volume 1 second ( FEV1 ) &gt; = 12 % &gt; = 200 mL qualify perform within 12 month Screening . If historical reversibility , subject must demonstrate absolute FEV1 &gt; = 12 % &gt; = 200 mL within 10 15 minute four puff salbutamol Visit 1 anytime prior Baseline . At Screening Baseline , FEV1 must &gt; = 50 % predict , restricted medication withhold appropriate interval . Complete blood count , blood chemistry , urinalysis , electrocardiogram ( ECG ) conduct Screening must within normal limit clinically acceptable investigator/sponsor . A chest xray perform Screening within 12 month prior must clinically acceptable . A female childbearing potential must use medically acceptable , adequate form birth control : prescribe hormonal contraceptive ; medically prescribe intrauterine device ( IUD ) ; medically prescribe transdermal contraceptive ; condom combination spermicide ; monogamous relationship male partner vasectomy . Birth control must start least 3 month prior Screening . Subject must agree continue use duration study . A subject childbearing potential currently sexually active must agree use medically acceptable method become sexually active study . Women surgically sterilize least 1 year postmenopausal consider childbearing potential . A subject childbearing potential must negative serum pregnancy test Screening . Key A change ( increase decrease ) absolute FEV1 &gt; 20 % time Screening Visit , include , Baseline Visit . A subject require use &gt; 12 inhalation per day shortacting betaagonist ( SABA ) MDI &gt; 2 nebulized treatment per day 2.5 mg salbutamol , 2 consecutive day Screening Visit , include , Baseline Visit . A subject experience clinical asthma exacerbation ( define deterioration asthma result emergency treatment , hospitalization due asthma , treatment additional , exclude asthma medication [ SABA ] ) time Screening Visit , include , Baseline Visit . A subject ever require ventilator support respiratory failure secondary asthma . A subject smoker exsmoker smoke within previous year cumulative smoking history &gt; 10 packyears .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>